Galecto Biotech
Series CGalecto Biotech raised €79M in a Series C round in Oct 2018. The company is based in Copenhagen, Denmark. Investors in the round: Bristol Myers Squibb, HBM Healthcare Investments, M Ventures and 6 others. Data as of 4 Nov 2026.
Amount raised
€79M
€79,000,000
Native amount
79,000,000 EUR
Stage
Series C
series c
Investors
9
Provenance & confidence
Low confidenceAmount
Reported in EUR — no conversion. €79M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
9 namedBristol Myers SquibbHBM Healthcare InvestmentsM VenturesMaverick VenturesNovo SeedsOrbiMedSeventure PartnersSunstone CapitalYsios Capital
Date
Oct 2018
Round type
series c
Amount (EUR)
€79M
Other rounds
same companyThis is the company's only recorded round.